Analgesic Efficacy of Bilateral US Guided TTPB vs ESPB in Pediatric Patients Undergoing Corrective Cardiac Surgeries
1 other identifier
interventional
30
1 country
1
Brief Summary
Corrective cardiac surgeries include a bundle of major surgeries that take place in pediatric patients and require imperative perioperative pain control; hence, the art of healing starts from trying to diminish or abolish pain. The use of highly potent opioids for paediatric cardiac anaesthesia has gained widespread popularity during the last 20 years . In addition to the important advantage of hemodynamic stability, the large-dose opioid-based anaesthetic techniques also blunt the stress response; however, large doses can cause over sedation, respiratory depression and prolonged mechanical ventilation after surgery . There are many ways to limit pain in such population with the topper potent opioids in the last several years. But new regional pain management modalities started to arise because of their known effect to diminish neuroendocrine stress response, provide excellent postoperative analgesia, and facilitate early postoperative extubation . Of the new evolving methods, the bilateral Transversus Thoracic Muscle Plane Block (TTPB) provides analgesia to the anterior chest wall and proved to be efficient in pediatric patients undergoing cardiac surgery using a median sternotomy approach . The bilateral Erector Spinae Plane Block (ESPB) is also one of the recently known pain controlling techniques used in pediatric cardiac surgeries. It became popular because it is much safer and easily administered than other alternative regional techniques as thoracic paravertebral and thoracic epidural block .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2022
CompletedFirst Posted
Study publicly available on registry
September 29, 2022
CompletedStudy Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 14, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 14, 2023
CompletedJanuary 9, 2024
January 1, 2024
11 months
September 26, 2022
January 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The total dose of intraoperative fentanyl
Amount of fentanyl required by patients in each group
All through the surgery
Secondary Outcomes (6)
Pain assessment
Immediately after admission to ICU then at 60 min, 2 hours, 4 hours, 8 hours and 12 hours postoperatively
Intra and postoperative haemodynamics including HR and MBP
Intraoperative T1: baseline reading 5 min after intubation, T2: after skin incision, T3: after sternotomy, T4: after aortic cannulation, T5: after weaning from bypass and T6: after skin closure then Immediately after admission to ICU, 1,2,4,8,12 hours
Total consumption of Fentanyl during the 1st 12 hours post operatively
Immediately after admission to ICU then at 60 min, 2 hours, 4 hours, 8 hours and 12 hours postoperatively
Time (in minutes) to 1st rescue analgesia (Fentanyl) post operatively
First 12 hours postoperatively
Time of extubation
First 12 hours postoperatively
- +1 more secondary outcomes
Study Arms (3)
Control
NO INTERVENTIONPatients in this group will receive fentanyl infusion at a dose of (0.5 μg/kg/h) all through the whole operation; in addition to 1μg/kg during skin incision, sternotomy, aortic cannulation and increase in MBP or HR more than 20% of the baseline readings.
Erector Spinae Plane Block
ACTIVE COMPARATORThis group will receive fentanyl infusion at a dose of (0.5 μg/kg / h) all through the whole operation plus Ultrasound guided bilateral ESPB which will be done by injecting 0.4 ml/kg (1:1 solution of bupivacaine 0.25% and lidocaine 1%) at each side
Transversus Thoracis Plane Block
EXPERIMENTALThis group will receive fentanyl infusion at a dose of (0.5 μg/kg / h) all through the whole operation plus ultrasound guided bilateral TTPB which will be done by injecting 0.4 ml/kg (1:1 solution of bupivacaine 0.25% and lidocaine 1%) at each side
Interventions
Under strict aseptic precautions, The T3 spinous process will be located. A high-frequency 12 MHz linear US transducer will be placed in a longitudinal orientation 3 cm lateral to the T3 spinous process corresponding to the T2 transverse process. Three muscles; trapezius (uppermost), rhomboids major (middle), and erector spinae (lowermost) will be identified superior to the hyperechoic transverse process. Using in-plane approach a 25 G needle will be inserted in caudal-cephalad direction, until the tip is deep to erector spinae muscle. Correct needle tip location will be confirmed by injecting 3 mL of normal saline and visualizing the linear LA spread (i.e., hydrodissection) in the fascial plane between the erector spinae muscle and the transverse process. Then, 0.4 ml/kg (1:1 solution of bupivacaine 0.25% and lidocaine 1%) will be injected and visualizing the linear LA spread in the fascial plane between the erector spinae muscle and the transverse process.
Under strict aseptic precautions, the T4-T5 intercostal space is identified under US using the US probe in the longitudinal plane 1 cm lateral to the sternal border. A high-frequency linear transducer is used. Next, a parasternal sagittal view of the intercostal muscle and the transverses thoracis muscle between the 4th and 5th rib is visualized above the pleura and a 22G, 5-10 cm needle is inserted in-plane (according to patient's body habitus and relevant anatomy) to the transducer with bevel up until the tip of the needle is located in the transverses thoracis muscles. After excluding intravascular and intrapleural placement, local anesthetic is adminstred bilaterally by injecting 0.4ml/kg (1:1 solution of bupivacaine 0.25% and lidocaine 1%) at each side.
Eligibility Criteria
You may qualify if:
- Age: 2 months - 4 years.
- ASA II and III.
- Patients undergoing corrective cardiac surgeries with midline sternotomy incision.
You may not qualify if:
- Patients whose parents or legal guardians refusing to participate.
- Preoperative mechanical ventilation.
- Preoperative inotropic drug infusion.
- Known or suspected coagulopathy.
- Known or suspected allergy to any of the studied drugs.
- Severe pulmonary hypertension.
- Cardiopulmonary bypass time more than 90 minutes.
- Aortic cross-clamp time more than 45 minutes.
- Total time from induction till ICU transfer more than 4 hours and 30 mins.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Abu Elrish hospitals
Cairo, Egypt
Related Publications (1)
Madkour MAFA, Abueldahab EIB, Elela AHA, Youssef MF, Gado AA. Analgesic Efficacy of Bilateral Ultrasound-Guided Transversus Thoracic Muscle Plane Block Versus Erector Spinae Plane Block in Pediatric Patients Undergoing Corrective Cardiac Surgeries: A Randomized Controlled Study. J Cardiothorac Vasc Anesth. 2025 Jun;39(6):1495-1505. doi: 10.1053/j.jvca.2025.03.001. Epub 2025 Mar 3.
PMID: 40122711DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Amel H Abo Elela, Professor
Cairo University
- STUDY DIRECTOR
Mohamed F Youssef, Professor
Cairo University
- STUDY DIRECTOR
Mai A Madkour, Professor
Cairo University
- STUDY DIRECTOR
Ahmed A Gado, Lecturer
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Randomization will be achieved by using an online random number generator. Patient codes will be placed into sequentially numbered sealed opaque envelopes by a research assistant who is not involved in the study. A medical doctor not involved in patient management will be responsible for opening the envelope and give the instructions contained within each envelope to the anesthesiologist who is expert in doing the ESPB in patients included within the block group. This expert anaesthesiologist will not be involved in collecting data but another anaesthesist blinded to the type of block will be responsible for patient management and collecting the intra-operative and postoperative data
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer
Study Record Dates
First Submitted
September 26, 2022
First Posted
September 29, 2022
Study Start
November 1, 2022
Primary Completion
September 14, 2023
Study Completion
September 14, 2023
Last Updated
January 9, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- November 2022 - November 2023
- Access Criteria
- URL
IPD collected in this study, including data dictionaries will be released to other researchers after the end of the study. All collected IPD, Study Protocol, Statistical Analysis Plan, Informed Consent Form, Clinical Study Report, Analytic Code all IPD that underlie results in a publication will be available